G 229
Pill imprint G 229 has been identified as Lamotrigine (chewable, dispersible) 25 mg.
Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; schizoaffective disorder; depression; anxiety (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy.
Lamotrigine 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Lamotrigine (chewable, dispersible) Images
- Imprint:
-
G
229 - Strength:
- 25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- aspartame
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
povidone k25
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0229
Advertisement
More Lamotrigine (Chewable, Dispersible) resources
- Lamotrigine (Wolters Kluwer)
- Lamotrigine Chewable Dispersible Tablets (Wolters Kluwer)
- Lamotrigine Extended-Release Tablets (Wolters Kluwer)
- Lamotrigine Orally Disintegrating Tablets (Wolters Kluwer)
- lamotrigine (Cerner Multum)
- lamotrigine (Micromedex) - Includes Dosage Information
- Lamotrigine (AHFS DI)
- Lamotrigine (FDA)
- Lamotrigine Tablets (FDA)
- Lamotrigine (Wolters Kluwer)
Search Again
